Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized - Report - MDSpire

Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized

  • By

  • Alastair D. Hay

  • Samantha Abbs

  • Matthew Ridd

  • Stephen Granier

  • J. Athene Lane

  • Peter Muir

  • Jodi Taylor

  • Grace Young

  • Kathy Eastwood

  • Hayley Dash

  • Lynne Bradshaw

  • Rebecca Clarke

  • Mandy Lui

  • Emma Bridgeman

  • Rachel C. M. Brierley

  • Emily Brown

  • Hannah V. Thornton

  • Paul M. Mitchell

  • Liang Zhu

  • Lucy Yardley

  • Chris Metcalfe

  • July 1, 2026

  • 0 min

Share

Clinical Report: Evaluation of Point-of-Care Microbiological Testing for Respiratory Infections

Overview

This randomized study evaluates the efficacy of rapid microbiological point-of-care tests (RM-POCT) in reducing same-day antibiotic prescribing for respiratory infections in primary care.

Background

Point-of-care tests (POCTs) are increasingly recognized for their potential to reduce unnecessary antibiotic prescriptions. The study focuses on RM-POCTs, which are designed to detect specific infections, yet their clinical utility in primary care remains under-researched.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • The study is the first randomized clinical trial assessing RM-POCT for respiratory infections.
  • Participants included patients aged 12 months and older with clinician-diagnosed respiratory infections.
  • Secondary objectives included evaluating symptom severity and healthcare utilization following RM-POCT use.
  • Potential weaknesses of RM-POCTs include the assumption that microbial detection correlates with clinical disease.

Clinical Implications

The findings from this study may inform clinicians about the role of RM-POCTs in antibiotic stewardship. Understanding the effectiveness of these tests could guide future clinical pathways and decision-making regarding antibiotic prescriptions.

Conclusion

This study contributes to the understanding of RM-POCTs in primary care settings.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2023 -- Evaluating the Effects of Point-of-Care Testing for Group A Streptococcal Pharyngitis on Antibiotic Use and Patient Outcomes in Outpatient Settings: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. Intensive Care Medicine, 2023 -- Evaluation of INHALE WP3: A Multicenter, Open-Label, Pragmatic Randomized Controlled Trial on the Effects of Rapid ICU-Based Syndromic PCR Compared to Standard Care on Antibiotic Stewardship and Clinical Outcomes in Hospital-Acquired and Ventilator-Associated Pneumonia
  3. Journal of General Internal Medicine, 2023 -- Letter to “Antibiotic Use in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter Retrospective Cohort Study”
  4. Open Forum Infectious Diseases, 2023 -- Addressing Current Evidence and Identifying Gaps in Diagnostics for Outpatient Respiratory Tract Infections: An Urgent Appeal
  5. Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management - NCBI Bookshelf, 2025
  6. Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial | Less is More | JAMA Internal Medicine, 2023
  7. Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies - PMC, 2023
  8. Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management - NCBI Bookshelf
  9. Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial | Less is More | JAMA Internal Medicine | JAMA Network
  10. Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies - PMC

Original Source(s)

Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized

  • by Alastair D. Hay, Samantha Abbs, Matthew Ridd, Stephen Granier, J. Athene Lane, Peter Muir, Jodi Taylor, Grace Young, Kathy Eastwood, Hayley Dash, Lynne Bradshaw, Rebecca Clarke, Mandy Lui, Emma Bridgeman, Rachel C. M. Brierley, Emily Brown, Hannah V. Thornton, Paul M. Mitchell, Liang Zhu, Lucy Yardley, Chris Metcalfe

  • July 1, 2026

Related Content

The reliability and diagnostic accuracy of the GAD-7 and GAD-2 for the most prevalent anxiety disorders in Latvian primary care

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

Demographic, social, psychological, mental health, and academic correlates of problematic smartphone use among French psychology students